Targeting CA125 transcription for ovarian cancer treatment.

被引：0
|
作者：
Yue, Er [1 ]
Yang, Guangchao [2 ]
Yao, Yuanfei [3 ]
Wang, Guangyu [3 ]
Zhang, Yanqiao [3 ]
Wang, Edward W. [1 ]
机构：
[1] City Hope Natl Med Ctr, Duarte, CA USA
[2] Harbin Med Univ, Affiliated Hosp 1, Harbin, Peoples R China
[3] Harbin Med Univ, Canc Hosp, Harbin, Peoples R China
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1153
引用
收藏
页数：2
相关论文
共 50 条
  • [31] INITIAL RESULTS WITH OVARIAN-CANCER ANTIGEN CA125
    CANNEY, PA
    MOORE, M
    JAMES, RD
    WILKINSON, PM
    BRITISH JOURNAL OF CANCER, 1984, 50 (02) : 261 - 261
  • [32] HE4 AND CA125 IN OVARIAN CANCER PATIENTS
    Kotowicz, B.
    Fuksiewicz, M.
    Kowalska, M.
    Sobiczewski, P.
    Skrzypczak, M.
    Spiewankiewicz, B.
    Kaminska, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [33] Targeting CA125 in cardiovascular disease
    Zeng, Guang-Gui
    Li, Heng
    Tang, Chao-Ke
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 357 : 122 - 122
  • [34] CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients - From The Danish "MALOVA" Ovarian Cancer Study
    Hogdall, Estrid V. S.
    Christensen, Lise
    Kjaer, Susanne K.
    Blaakaer, Jan
    Kjaerbye-Thygesen, Anette
    Gayther, Simon
    Jacobs, Ian J.
    Hogdall, Claus K.
    GYNECOLOGIC ONCOLOGY, 2007, 104 (03) : 508 - 515
  • [35] Monoclonal antibody (Oregovomab) targeting of CA125 in patients (Pts) with advanced epithelial ovarian cancer (EOC) and elevated CA125 after response to initial therapy.
    Bookman, M
    Rettenmaier, M
    Gordon, A
    Tuccillo, D
    Fingert, H
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3756S - 3756S
  • [36] TP53 autoantibody can detect CA125 screen negative ovarian cancer cases and can be elevated prior to CA125 in preclinical ovarian cancer
    Yang, Wei-Lei
    Simmons, Archana
    Lu, Zhen
    Baggerly, Keith
    Lu, Karen
    Gentry-Maharaj, Alex
    Menon, Usha
    Jacobs, Ian
    Bast, Robert C.
    CANCER RESEARCH, 2015, 75
  • [37] Predicting response of ovarian cancer to paclitaxel treatment based on trend analysis of serum CA125
    Nekulova, M
    Pecen, L
    Kalabova, R
    Simickova, M
    Topolcan, O
    Pikner, R
    Vondracek, V
    Valik, D
    CLINICAL CHEMISTRY, 2002, 48 (08) : 1364 - 1367
  • [38] CLINICAL SIGNIFICANCE OF CA125 VALUES AFTER PRIMARY TREATMENT IN SURVIVAL OF PATIENTS WITH OVARIAN CANCER
    Byun, S. W.
    Jang, H. K.
    Park, T. C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1453 - 1453
  • [39] Diagnostic value of CA125 as a predictor of recurrence in advanced ovarian cancer
    Song, M. J.
    Lee, S. H.
    Choi, M. R.
    Son, H. J.
    Lee, C. W.
    Yoon, J. H.
    Park, Y. G.
    Hur, S. Y.
    Ryu, K. S.
    Lee, J. M.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2013, 34 (02) : 148 - 151
  • [40] COMBINATION OF IMMUNOSCINTIGRAPHY AND CA125 SERUM LEVELS IN OVARIAN-CANCER
    SCHATTEN, C
    PATEISKEY, N
    SEVELDA, P
    CZERWENKA, K
    BARRADA, M
    PHILIPP, K
    BURCHELL, J
    BRITISH JOURNAL OF CANCER, 1989, 59 (02) : 322 - 322
12345